<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">30619331</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>10</Month>
        <Day>21</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>06</Month>
        <Day>04</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">1664-3224</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>9</Volume>
            <PubDate>
              <Year>2018</Year>
            </PubDate>
          </JournalIssue>
          <Title>Frontiers in immunology</Title>
          <ISOAbbreviation>Front Immunol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>How Should We Classify Kawasaki Disease?</ArticleTitle>
        <Pagination>
          <StartPage>2974</StartPage>
          <MedlinePgn>2974</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">2974</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2018.02974</ELocationID>
        <Abstract>
          <AbstractText>The exact classification of Kawasaki disease (KD) has been debated. Infectious disease specialists have claimed it as an infection with a classic immune responses to an as yet unidentified pathogen that localizes to the coronary arteries. Others have favored an autoreactive hypothesis that KD is triggered by an antigen that shares homology with structures in the vascular wall, and molecular mimicry resulting in an immune response directed to that tissue. Rheumatologists have classified it as a systemic vasculitis, while some immunologists have stressed the robust nature of the innate immune response that causes both systemic inflammation as well as damage to the coronary arterial wall and questioned whether KD falls within the spectrum of autoinflammatory diseases. This review will describe the evidences available up to now regarding these hypotheses.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Marrani</LastName>
            <ForeName>Edoardo</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Rheumatology Unit, Department of Neurosciences, Psychology, Drug Research and Child Health, Meyer Children's Hospital, University of Florence, Florence, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Burns</LastName>
            <ForeName>Jane C</ForeName>
            <Initials>JC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Kawasaki Disease Research Center, Rady Children's Hospital, University of California, San Diego, San Diego, CA, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cimaz</LastName>
            <ForeName>Rolando</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Rheumatology Unit, Department of Neurosciences, Psychology, Drug Research and Child Health, Meyer Children's Hospital, University of Florence, Florence, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>12</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Front Immunol</MedlineTA>
        <NlmUniqueID>101560960</NlmUniqueID>
        <ISSNLinking>1664-3224</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001327" MajorTopicYN="N">Autoimmune Diseases</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003331" MajorTopicYN="N">Coronary Vessels</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D056660" MajorTopicYN="N">Hereditary Autoinflammatory Diseases</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009080" MajorTopicYN="N">Mucocutaneous Lymph Node Syndrome</DescriptorName>
          <QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName>
          <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D056647" MajorTopicYN="N">Systemic Vasculitis</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Kawasaki disease</Keyword>
        <Keyword MajorTopicYN="Y">coronary aneurysm</Keyword>
        <Keyword MajorTopicYN="Y">etiopathogenesis</Keyword>
        <Keyword MajorTopicYN="Y">intravenous immune globulin (IVIg)</Keyword>
        <Keyword MajorTopicYN="Y">pediatric vasculitis</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>12</Month>
          <Day>3</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>1</Month>
          <Day>9</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>1</Month>
          <Day>9</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30619331</ArticleId>
        <ArticleId IdType="pmc">PMC6302019</ArticleId>
        <ArticleId IdType="doi">10.3389/fimmu.2018.02974</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Burns JC, Glodé MP. Kawasaki syndrome. Lancet (2004) 364:533–44. 10.1016/S0140-6736(04)16814-1</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(04)16814-1</ArticleId>
            <ArticleId IdType="pubmed">15302199</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suzuki A, Kamiya T, Kuwahara N, Ono Y, Kohata T, Takahashi O, et al. . Coronary arterial lesions of Kawasaki disease: cardiac catheterization findings of 1100 cases. Pediatr Cardiol. (1986) 7:3–9. 10.1007/BF02315475</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/BF02315475</ArticleId>
            <ArticleId IdType="pubmed">3774580</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tremoulet AH, Best BM, Song S, Wang S, Corinaldesi E, Eichenfield JR, et al. . Resistance to intravenous immunoglobulin in children with Kawasaki disease. J Pediatr. (2008) 153:117–121.e3. 10.1016/j.jpeds.2007.12.021</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jpeds.2007.12.021</ArticleId>
            <ArticleId IdType="pmc">PMC2526555</ArticleId>
            <ArticleId IdType="pubmed">18571548</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. . Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the american heart association. Circulation (2017) 135:e927–999. 10.1161/CIR.0000000000000484</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIR.0000000000000484</ArticleId>
            <ArticleId IdType="pubmed">28356445</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bar-Meir M, Kalisky I, Schwartz A, Somekh E, Tasher D, Israeli Kawasaki group. Prediction of resistance to intravenous immunoglobulin in children with Kawasaki disease. J Pediatric Infect Dis Soc. (2018) 7:25–9. 10.1093/jpids/piw075</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jpids/piw075</ArticleId>
            <ArticleId IdType="pubmed">28062554</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Phuong LK, Curtis N, Gowdie P, Akikusa J, Burgner D. Treatment options for resistant Kawasaki disease. Pediatr Drugs (2018) 20:59–80. 10.1007/s40272-017-0269-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s40272-017-0269-6</ArticleId>
            <ArticleId IdType="pubmed">29101553</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rowley AH.
Is Kawasaki disease an infectious disorder? Int J Rheum Dis. (2018) 21:20–5. 10.1111/1756-185X.13213</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/1756-185X.13213</ArticleId>
            <ArticleId IdType="pmc">PMC5777874</ArticleId>
            <ArticleId IdType="pubmed">29105346</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mahr A, de Menthon M. Classification and classification criteria for vasculitis. Curr Opin Rheumatol. (2015) 27:1–9. 10.1097/BOR.0000000000000134</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/BOR.0000000000000134</ArticleId>
            <ArticleId IdType="pubmed">25415531</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burns JC, Koné-Paut I, Kuijpers T, Shimizu C, Tremoulet A, Arditi M. Review: found in translation: international initiatives pursuing interleukin-1 blockade for treatment of acute Kawasaki disease. Arthritis Rheumatol. (2017) 69:268–76. 10.1002/art.39975</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/art.39975</ArticleId>
            <ArticleId IdType="pmc">PMC5274552</ArticleId>
            <ArticleId IdType="pubmed">27792871</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miura M, Kobayashi T, Kaneko T, Ayusawa M, Fukazawa R, Fukushima N, et al. . Association of severity of coronary artery aneurysms in patients with Kawasaki disease and risk of later coronary events. JAMA Pediatr. (2018) 172:1–8. 10.1001/jamapediatrics.2018.0030</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamapediatrics.2018.0030</ArticleId>
            <ArticleId IdType="pmc">PMC5875323</ArticleId>
            <ArticleId IdType="pubmed">29507955</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takahashi K, Oharaseki T, Naoe S, Wakayama M, Yokouchi Y. Neutrophilic involvement in the damage to coronary arteries in acute stage of Kawasaki disease. Pediatr Int. (2005) 47:305–10. 10.1111/j.1442-200x.2005.02049.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1442-200x.2005.02049.x</ArticleId>
            <ArticleId IdType="pubmed">15910456</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Orenstein JM, Shulman ST, Fox LM, Baker SC, Takahashi M, Bhatti TR, et al. . Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study. PLoS ONE (2012) 7:e38998. 10.1371/journal.pone.0038998</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0038998</ArticleId>
            <ArticleId IdType="pmc">PMC3377625</ArticleId>
            <ArticleId IdType="pubmed">22723916</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tsuda E, Hirata T, Matsuo O, Abe T, Sugiyama H, Yamada O. The 30-year outcome for patients after myocardial infarction due to coronary artery lesions caused by Kawasaki disease. Pediatr Cardiol. (2011) 32:176–82. 10.1007/s00246-010-9838-y</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00246-010-9838-y</ArticleId>
            <ArticleId IdType="pubmed">21120463</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yonesaka S, Nakada T, Sunagawa Y, Tomimoto K, Naka S, Takahashi T, et al. . Endomyocardial biopsy in children with Kawasaki disease. Acta Paediatr Jpn Overseas Ed. (1989) 31:706–11. 10.1111/j.1442-200X.1989.tb01384.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1442-200X.1989.tb01384.x</ArticleId>
            <ArticleId IdType="pubmed">2516398</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Numano F, Shimizu C, Jimenez-Fernandez S, Vejar M, Oharaseki T, Takahashi K, et al. . Galectin-3 is a marker of myocardial and vascular fibrosis in Kawasaki disease patients with giant aneurysms. Int J Cardiol. (2015) 201:429–37. 10.1016/j.ijcard.2015.07.063</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijcard.2015.07.063</ArticleId>
            <ArticleId IdType="pubmed">26313861</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yonesaka S, Takahashi T, Eto S, Sato T, Otani K, Ueda T, et al. . Biopsy-proven myocardial sequels in Kawasaki disease with giant coronary aneurysms. Cardiol Young. (2010) 20:602–9. 10.1017/S1047951109991132</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1017/S1047951109991132</ArticleId>
            <ArticleId IdType="pubmed">20584347</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martin M, Wrotniak BH, Hicar M. Suppressed plasmablast responses in febrile infants, including children with Kawasaki disease. PLoS ONE (2018):13:e0193539. 10.1371/journal.pone.0193539</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0193539</ArticleId>
            <ArticleId IdType="pmc">PMC5868766</ArticleId>
            <ArticleId IdType="pubmed">29579044</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rowley AH, Baker SC, Shulman ST, Garcia FL, Fox LM, Kos IM, et al. 
RNA-containing cytoplasmic inclusion bodies in ciliated bronchial epithelium months to years after acute Kawasaki disease. Ratner A, ed. PLoS ONE (2008) 3:e1582
10.1371/journal.pone.0001582</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0001582</ArticleId>
            <ArticleId IdType="pmc">PMC2216059</ArticleId>
            <ArticleId IdType="pubmed">18270572</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rowley AH, Shulman ST, Spike BT, Mask CA, Baker SC. Oligoclonal IgA response in the vascular wall in acute kawasaki disease. J Immunol. (2001) 166:1334–43. 10.4049/jimmunol.166.2.1334</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.166.2.1334</ArticleId>
            <ArticleId IdType="pubmed">11145718</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rowley AH, Shulman ST, Garcia FL, Guzman-Cottrill JA, Miura M, Lee HL, et al. . Cloning the arterial IgA antibody response during acute kawasaki disease. J Immunol. (2005) 175:8386–91. 10.4049/jimmunol.175.12.8386</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.175.12.8386</ArticleId>
            <ArticleId IdType="pubmed">16339580</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoang LT, Shimizu C, Ling L, Naim AN, Khor CC, Tremoulet AH, et al. . Global gene expression profiling identifies new therapeutic targets in acute Kawasaki disease. Genome Med. (2014) 6:1–13. 10.1186/s13073-014-0102-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13073-014-0102-6</ArticleId>
            <ArticleId IdType="pmc">PMC4279699</ArticleId>
            <ArticleId IdType="pubmed">25614765</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Popper SJ, Watson VE, Shimizu C, Kanegaye JT, Burns JC, Relman DA. Gene transcript abundance profiles distinguish Kawasaki disease from adenovirus infection. J Infect Dis. (2009) 200:657–66. 10.1086/603538</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/603538</ArticleId>
            <ArticleId IdType="pmc">PMC2878183</ArticleId>
            <ArticleId IdType="pubmed">19583510</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wright VJ, Herberg JA, Kaforou M, Shimizu C, Eleftherohorinou H, Shailes H, et al. . Diagnosis of Kawasaki disease using a minimal whole-blood gene expression signature. JAMA Pediatr. (2018) 172:e182293. 10.1001/jamapediatrics.2018.2293</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamapediatrics.2018.2293</ArticleId>
            <ArticleId IdType="pmc">PMC6233768</ArticleId>
            <ArticleId IdType="pubmed">30083721</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McGonagle D, McDermott MF. A proposed classification of the immunological diseases. PLoS Med. (2006) 3:1242–8. 10.1371/journal.pmed.0030297</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pmed.0030297</ArticleId>
            <ArticleId IdType="pmc">PMC1564298</ArticleId>
            <ArticleId IdType="pubmed">16942393</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Niewold TB, Wu SC, Smith M, Morgan GA, Pachman LM. Familial aggregation of autoimmune disease in juvenile dermatomyositis. Pediatrics. (2011) 127:e1239–46. 10.1542/peds.2010-3022</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1542/peds.2010-3022</ArticleId>
            <ArticleId IdType="pmc">PMC3081190</ArticleId>
            <ArticleId IdType="pubmed">21502224</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Prahalad S, McCracken CE, Ponder LA, Angeles-Han ST, Rouster Stevens KA, Vogler LB, et al. . Familial autoimmunity in the childhood arthritis and rheumatology research alliance registry. Pediatr Rheumatol Online J. (2016) 14:14. 10.1186/s12969-016-0075-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12969-016-0075-7</ArticleId>
            <ArticleId IdType="pmc">PMC4785640</ArticleId>
            <ArticleId IdType="pubmed">26965173</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tronconi E, Miniaci A, Pession A. The autoimmune burden in juvenile idiopathic arthritis. Ital J Pediatr. (2017) 43:56. 10.1186/s13052-017-0373-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13052-017-0373-9</ArticleId>
            <ArticleId IdType="pmc">PMC5471888</ArticleId>
            <ArticleId IdType="pubmed">28615030</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Makino N, Nakamura Y, Yashiro M, Sano T, Ae R, Kosami K, et al. . Epidemiological observations of Kawasaki disease in Japan, 2013–2014. Pediatr Int. (2018) 60:581–7. 10.1111/ped.13544</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/ped.13544</ArticleId>
            <ArticleId IdType="pubmed">29498791</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim GB, Park S, Eun LY, Han JW, Lee SY, Yoon KL, et al. . Epidemiology and clinical features of kawasaki disease in South Korea, 2012–2014. Pediatric Infect Dis J. (2017) 36:2012–4. 10.1097/INF.0000000000001474</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/INF.0000000000001474</ArticleId>
            <ArticleId IdType="pubmed">27997519</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stagi S, Simonini G, Ricci L, de Martino M, Falcini F. Coeliac disease in patients with Kawasaki disease. Is there a link?
Rheumatology (2006) 45:847–50. 10.1093/rheumatology/kel007</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/rheumatology/kel007</ArticleId>
            <ArticleId IdType="pubmed">16418194</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dos Santos Domingues A, Selleski N, Uenishi RH, Medeiros Ribeiro de Magalhães C, Gandolfi L, Pratesi CB.
The possible link between coeliac and Kawasaki diseases in Brazil: a cross-sectional study. BMJ Open (2018) 8:e018803.10.1136/bmjopen-2017-018803</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmjopen-2017-018803</ArticleId>
            <ArticleId IdType="pmc">PMC5829591</ArticleId>
            <ArticleId IdType="pubmed">29444780</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cho HK, Eun LY, Song J-S, Kang WH, Ro BI. A case of vitiligo after Kawasaki's disease. Ann Dermatol. (2009) 21:75. 10.5021/ad.2009.21.1.75</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5021/ad.2009.21.1.75</ArticleId>
            <ArticleId IdType="pmc">PMC2883377</ArticleId>
            <ArticleId IdType="pubmed">20548863</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jiang Z-G, Liu L, Yang C-Y, Wu J. Value of anti-neutrophil cytoplasmic antibody in diagnosis of Kawasaki disease. Zhongguo Dang Dai Er Ke Za Zhi. (2012) 14:45–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22289752</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao J-M, Wang X-H. Clinical significance of anti-neutrophil cytoplasmic antibodies and anti-endothelial cell antibodies in children with Kawasaki disease. Zhongguo Dang Dai Er Ke Za Zhi. (2014) 16:740–4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25008884</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guzman J, Fung M, Petty RE. Diagnostic value of anti-neutrophil cytoplasmic and anti-endothelial cell antibodies in early Kawasaki disease. J Pediatr. (1994) 124:917–20. 10.1016/S0022-3476(05)83180-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0022-3476(05)83180-4</ArticleId>
            <ArticleId IdType="pubmed">8201476</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nash MC, Shah V, Reader JA, Dillon MJ.
Anti-neutrophil cytoplasmic antibodies and anti-endothelial cell antibodies are not increased in Kawasaki disease. Br J Rheumatol. (1995) 34:882–7. 10.1093/rheumatology/34.9.882</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/rheumatology/34.9.882</ArticleId>
            <ArticleId IdType="pubmed">7582731</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cunningham MW, Meissner HC, Heuser JS, Pietra BA, Kurahara DK, Leung DY. Anti-human cardiac myosin autoantibodies in Kawasaki syndrome. J Immunol. (1999) 163:1060–5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10395705</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tizard EJ, Baguley E, Hughes GR, Dillon MJ. Antiendothelial cell antibodies detected by a cellular based ELISA in Kawasaki disease. Arch Dis Child. (1991) 66:189–92. 10.1136/adc.66.2.189</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/adc.66.2.189</ArticleId>
            <ArticleId IdType="pmc">PMC1792841</ArticleId>
            <ArticleId IdType="pubmed">1900406</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guilpain P, Mouthon L. Antiendothelial Cells Autoantibodies in Vasculitis-Associated Systemic Diseases. Clin Rev Allergy Immunol. (2008) 35:59–65. 10.1007/s12016-007-8069-3</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12016-007-8069-3</ArticleId>
            <ArticleId IdType="pubmed">18228162</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Legendre P, Régent A, Thiebault M, Mouthon L. Anti-endothelial cell antibodies in vasculitis: a systematic review. Autoimmun Rev. (2017) 16:146–53. 10.1016/j.autrev.2016.12.012</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.autrev.2016.12.012</ArticleId>
            <ArticleId IdType="pubmed">27989761</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grunebaum E, Blank M, Cohen S, Afek A, Kopolovic J, Meroni PL, et al. . The role of anti-endothelial cell antibodies in Kawasaki disease - In vitro and in vivo studies. Clin Exp Immunol. (2002) 130:233–40. 10.1046/j.1365-2249.2002.02000.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1365-2249.2002.02000.x</ArticleId>
            <ArticleId IdType="pmc">PMC1906533</ArticleId>
            <ArticleId IdType="pubmed">12390310</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Franco A, Touma R, Song Y, Shimizu C, Tremoulet AH, Kanegaye JT, et al. . Specificity of regulatory T cells that modulate vascular inflammation. Autoimmunity (2014) 47:95–104. 10.3109/08916934.2013.860524</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/08916934.2013.860524</ArticleId>
            <ArticleId IdType="pubmed">24490882</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burns JC, Song Y, Bujold M, Shimizu C, Kanegaye JT, Tremoulet AH, et al. . Immune-monitoring in Kawasaki disease patients treated with infliximab and intravenous immunoglobulin. Clin Exp Immunol. (2013) 174:337–44. 10.1111/cei.12182</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/cei.12182</ArticleId>
            <ArticleId IdType="pmc">PMC3826300</ArticleId>
            <ArticleId IdType="pubmed">23901839</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McDermott MF, Aksentijevich I, Galon J, McDermott EM, Ogunkolade BW, Centola M, et al. . Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell (1999) 97:133–44. 10.1016/S0092-8674(00)80721-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0092-8674(00)80721-7</ArticleId>
            <ArticleId IdType="pubmed">10199409</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lucherini OM, Rigante D, Sota J, Fabiani C, Obici L, Cattalini M, et al. . Updated overview of molecular pathways involved in the most common monogenic autoinflammatory diseases. Clin Exp Rheumatol. (2018) 36 (Suppl. 1):3–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29742053</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rigante D. The fresco of autoinflammatory diseases from the pediatric perspective. Autoimmun Rev. (2012) 11:348–56. 10.1016/j.autrev.2011.10.008</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.autrev.2011.10.008</ArticleId>
            <ArticleId IdType="pubmed">22024500</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leung DY, Cotran RS, Kurt-Jones E, Burns JC, Newburger JW, Pober JS. Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease. Lancet (1989) 2:1298–302. 10.1016/S0140-6736(89)91910-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(89)91910-7</ArticleId>
            <ArticleId IdType="pubmed">2480498</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fury W, Tremoulet AH, Watson VE, Best BM, Shimizu C, Hamilton J, et al. . Transcript abundance patterns in Kawasaki disease patients with intravenous immunoglobulin resistance. Hum Immunol. (2010) 71:865–73. 10.1016/j.humimm.2010.06.008</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.humimm.2010.06.008</ArticleId>
            <ArticleId IdType="pmc">PMC2929310</ArticleId>
            <ArticleId IdType="pubmed">20600450</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lehman TJ, Walker SM, Mahnovski V, McCurdy D. Coronary arteritis in mice following the systemic injection of group B Lactobacillus casei cell walls in aqueous suspension. Arthritis Rheum. (1985) 28:652–9. 10.1002/art.1780280609</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/art.1780280609</ArticleId>
            <ArticleId IdType="pubmed">3924060</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ohno N. Murine model of Kawasaki disease induced by mannoprotein-beta-glucan complex, CAWS, obtained from Candida albicans. Jpn J Infect Dis. (2004) 57:S9–10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15507772</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee Y, Wakita D, Dagvadorj J, Shimada K, Chen S, Huang G, et al. . IL-1 Signaling Is critically required in stromal cells in kawasaki disease vasculitis mouse model: role of both IL-1α and IL-1β. Arterioscler Thromb Vasc Biol. (2015) 35:2605–616. 10.1161/ATVBAHA.115.306475</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/ATVBAHA.115.306475</ArticleId>
            <ArticleId IdType="pmc">PMC4662607</ArticleId>
            <ArticleId IdType="pubmed">26515418</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wakita D, Kurashima Y, Crother TR, Noval Rivas M, Lee Y, Chen S, et al. . Role of Interleukin-1 signaling in a mouse model of kawasaki disease-associated abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol. (2016) 36:886–97. 10.1161/ATVBAHA.115.307072</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/ATVBAHA.115.307072</ArticleId>
            <ArticleId IdType="pmc">PMC4850105</ArticleId>
            <ArticleId IdType="pubmed">26941015</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jain A, Song R, Wakeland EK, Pasare C. T cell-intrinsic IL-1R signaling licenses effector cytokine production by memory CD4 T cells. Nat Commun. (2018) 9:3185. 10.1038/s41467-018-05489-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41467-018-05489-7</ArticleId>
            <ArticleId IdType="pmc">PMC6085393</ArticleId>
            <ArticleId IdType="pubmed">30093707</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cohen S, Tacke CE, Straver B, Meijer N, Kuipers IM, Kuijpers TW. A child with severe relapsing Kawasaki disease rescued by IL-1 receptor blockade and extracorporeal membrane oxygenation. Ann Rheum Dis. (2012) 71:2059–61. 10.1136/annrheumdis-2012-201658</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/annrheumdis-2012-201658</ArticleId>
            <ArticleId IdType="pubmed">22689319</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shafferman A, Birmingham JD, Cron RQ. High dose anakinra for treatment of severe neonatal Kawasaki disease: a case report. Pediatr Rheumatol. (2014) 12:26. 10.1186/1546-0096-12-26</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1546-0096-12-26</ArticleId>
            <ArticleId IdType="pmc">PMC4103976</ArticleId>
            <ArticleId IdType="pubmed">25045337</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sánchez-Manubens J, Gelman A, Franch N, Teodoro S, Palacios JR, Rudi N, et al. . A child with resistant Kawasaki disease successfully treated with anakinra: a case report. BMC Pediatr. (2017) 17:102. 10.1186/s12887-017-0852-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12887-017-0852-6</ArticleId>
            <ArticleId IdType="pmc">PMC5385011</ArticleId>
            <ArticleId IdType="pubmed">28390409</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guillaume M-P, Reumaux H, Dubos F. Usefulness and safety of anakinra in refractory Kawasaki disease complicated by coronary artery aneurysm. Cardiol Young. (2018) 28:739–42. 10.1017/S1047951117002864</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1017/S1047951117002864</ArticleId>
            <ArticleId IdType="pubmed">29455693</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kone-Paut I, Cimaz R, Herberg J, Bates O, Carbasse A, Saulnier JP, et al. . The use of interleukin 1 receptor antagonist (anakinra) in Kawasaki disease: a retrospective cases series. Autoimmun Rev. (2018) 17:768–74. 10.1016/j.autrev.2018.01.024</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.autrev.2018.01.024</ArticleId>
            <ArticleId IdType="pubmed">29885546</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blonz G, Lacroix S, Benbrik N, Warin-Fresse K, Masseau A, Trewick D, et al. . Severe late-onset kawasaki disease successfully treated with anakinra. J Clin Rheumatol. (2018). 10.1097/RHU.0000000000000814. [Epub ahead of print].</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/RHU.0000000000000814</ArticleId>
            <ArticleId IdType="pubmed">32073531</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Onouchi Y. The genetics of Kawasaki disease. Int J Rheum Dis. (2018) 21:26–30. 10.1111/1756-185X.13218</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/1756-185X.13218</ArticleId>
            <ArticleId IdType="pubmed">29152908</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yorifuji T, Tsukahara H, Doi H. Breastfeeding and risk of Kawasaki disease: a nationwide longitudinal survey in Japan. Pediatrics (2016) 137:e20153919. 10.1542/peds.2015-3919</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1542/peds.2015-3919</ArticleId>
            <ArticleId IdType="pubmed">27244853</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maddox RA, Holman RC, Uehara R, Callinan LS, Guest JL, Schonberger LB, et al. . Recurrent Kawasaki disease: USA and Japan. Pediatr Int. (2015) 57:1116–20. 10.1111/ped.12733</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/ped.12733</ArticleId>
            <ArticleId IdType="pmc">PMC4676732</ArticleId>
            <ArticleId IdType="pubmed">26096590</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Okubo Y, Nochioka K, Sakakibara H, Testa M, Sundel RP. National survey of pediatric hospitalizations due to Kawasaki disease and coronary artery aneurysms in the USA. Clin Rheumatol. (2017) 36:413–419. 10.1007/s10067-016-3512-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10067-016-3512-6</ArticleId>
            <ArticleId IdType="pubmed">27987089</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Uehara R, Yashiro M, Nakamura Y, Yanagawa H. Kawasaki disease in parents and children. Pediatr Infect Dis J. (2003) 92:694–7. 10.1111/j.1651-2227.2003.tb00602.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1651-2227.2003.tb00602.x</ArticleId>
            <ArticleId IdType="pubmed">12856980</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Uehara R, Belay ED. Epidemiology of Kawasaki disease in Asia, Europe, and the United States. J Epidemiol. (2012) 22:79–85. 10.2188/jea.JE20110131</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2188/jea.JE20110131</ArticleId>
            <ArticleId IdType="pmc">PMC3798585</ArticleId>
            <ArticleId IdType="pubmed">22307434</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Manlhiot C, Mueller B, O'Shea S, Majeed H, Bernknopf B, Labelle M, et al. . Environmental epidemiology of Kawasaki disease: Linking disease etiology, pathogenesis and global distribution. PLoS ONE (2018) 13:1–17. 10.1371/journal.pone.0191087</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0191087</ArticleId>
            <ArticleId IdType="pmc">PMC5802431</ArticleId>
            <ArticleId IdType="pubmed">29415012</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
